InCarda Therapeutics, Inc.
2 clinical trials · Sponsor
◉ Watch InCarda Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation (NCT05039359) | InCarda Therapeutics, Inc. | 2022-04-26 |
| INhalation of Flecainide to Convert Recent Onset SympTomatic Atrial Fibrillation to siNus rhyThm (INSTANT) (NCT03539302) | InCarda Therapeutics, Inc. | 2018-05-29 |
Track InCarda Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.